Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 3 I, 1996, Pages 602-611

  Goodman, Richard B ^a   Strieter, Robert M ^b   Martin, Diane P ^b   Steinberg, Kenneth P ^b   Milberg, John A ^b   Maunder, Richard J ^b   Kunkel, Steven L ^b   Walz, Alfred ^b   Hudson, Leonard D ^b   Martin, Thomas R ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CELL POPULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LUNG INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL;

EID: 10144244653     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.3.8810593     Document Type: Article

References (70)

1. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. Legall, A. Morris, and R. Spragg. 1994. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149:818-824.
2. Bachofen, M., and E. R. Weibel. 1982. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med. 3:35-56.
3. Tate, R. M., and J. E. Repine. 1983. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. 128:552-559.
4. Idell, S., and A. B. Cohen. 1985. Bronchoalveolar lavage in patients with the adult respiratory distress syndrome. Clin. Chest Med. 6: 459-471.
5. Lee, C. T., A. M. Fein, M. Lippman, H. Holtzman, P. Kimbel, and G. Weinbaum. 1981. Elastolytic activity in pulmonary lavage fluid from patients with the adult respiratory distress syndrome. N. Engl. J. Med. 304:192-196.
6. Shasby, D. M., R. B. Fox, R. N. Harada, and J. E. Repine. 1982. Reduction of the edema of acute hyperoxic lung injury by granulocyte depletion. J. Appl. Physiol. 52:1237-1244.
7. Rinaldo, J. E., and H. Borovetz. 1985. Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury. Am. Rev. Respir. Dis. 131:579-583.
8. Lo, S. K., J. Everitt, J. Gu, and A. B. Malik. 1992. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J. Clin. Invest. 89:981-988.
9. Windsor, A. C. J., C. J. Walsh, P. G. Mullen, D. J. Cook, B. J. Fisher, C. R. Blocher, S. K. Leeper-Woodford, H. J. Sugerman, and A. A. Fowler. 1993. Tumor necrosis factor-α blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J. Clin. Invest. 91:1459-1468.
10. Harada, A., N. Sekido, T. Akahoshi, T. Wada, N. Mukaida, and K. Matsushima. 1994. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukocyte Biol. 56:559-564.
11. Weiland, J. E., W. B. Davis, J. F. Holter, J. R. Mohammed, P. M. Dorinsky, and J. E. Gadek. 1986. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Am. Rev. Respir. Dis. 133:218-225.
12. Steinberg, K. P., J. A. Milberg, T. R. Martin, R. J. Maunder, B. A. Cockrill, and L. D. Hudson. 1994. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150:113-122.
13. Leibovich, S. J., and R. Ross. 1975. The role of the macrophage in wound repair. Am. J. Pathol. 78:71-100.
14. Parsons, P. E., A. A. Fowler, T. M. Hyers, and P. M. Henson. 1985. Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory disress syndrome. Am. Rev. Respir. Dis. 132: 490-493.
15. Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Walz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, and C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643-647.
16. Miller, E. J., A. B. Cohen, S. Nagao, D. Griffith, R. J. Maunder, T. R. Martin, J. P. Weiner-Kronish, M. Sticherling, E. Christophers, and M. A. Matthay. 1992. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427-432.
17. Steinberg, K. P., D. R. Mitchell, R. J. Maunder, J. A. Milberg, M. E. Whitcomb, and L. D. Hudson. 1993. Safety of bronchoalveolar lavage in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 148:556-561.
18. Pepe, P. E., R. T. Potkin, D. H. Reus, L. D. Hudson, and C. J. Carrico. 1982. Clinical predictors of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132:485-489.
19. Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Baird, D. J. Eberle, T. L. Petty, and T. M. Hyers. 1983. Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 98:593-597.
20. Hudson, L. D., J. A. Milberg, D. Anardi, and R. J. Maunder. 1995. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151:293-301.
21. Murray, J. F., M. A. Matthay, J. M. Luce, and M. R. Flick. 1988. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-723.
22. McHugh, L. G., J. A. Milberg, M. E. Whitcomb, R. B. Schoene, R. J. Maunder, and L. D. Hudson. 1994. Recovery of function in survivors of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150:90-94.
23. Martin, T. R., B. P. Pistorese, E. Y. Chi, R. B. Goodman, and M. A. Matthay. 1989. The effects of leukotriene B4 in the human lung: recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J. Clin. Invest. 84:1609-1619.
24. Strieter, R. M., S. L. Kunkel, M. D. Burdick, P. M. Lincoln, and A. Walz. 1992. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol. Invest. 121:589-596.
25. Evanoff, H. L., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Strieter. 1992. A sensitive ELISA for the detection of human moncyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 21:39-45.
26. Koch, A. E., S. L. Kunkel, L. A. Harlow, D. D. Mazarakis, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Strieter. 1994. Macrophage inflammatory protein-1α: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J. Clin. Invest. 93:921-928.
27. Kasama, T., R. M. Strieter, T. J. Standiford, M. D. Burdick, and S. L. Kunkel. 1993. Expression and regulation of human neutrophil-derived macrophage inflammatory protein-1α. J. Exp. Med. 178:63-72.
28. Moore, S. A., R. M. Strieter, M. W. Rolfe, T. J. Standiford, M. D. Burdick, and S. L. Kunkel. 1992. Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am. J. Respir. Cell Mol. Biol. 6:569-575.
29. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
30. Goodman, R. B., R. G. Wood, T. R. Martin, O, Hanson-Painton, and G. T. Kinasewitz. 1992. Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8. J. Immunol. 148:457-465.
31. Goodman, R. B., J. W. Forstrom, S. G. Osborn, E. Y. Chi, and T. R. Martin. 1991. Identification of two neutrophil chemotactic peptides produced by porcine alveolar macrophages. J. Biol. Chem. 266: 8455-8463.
32. Kleinbaum, D. G., L. L. Kupper, and K. E. Muller. 1988. Applied Regression Analysis and Other Multivariate Methods, 2nd ed. PWS-Kent Publishing Co., Boston, MA.
33. Holter, J. F., J. E. Weiland, E. R. Pacht, J. E. Gadek, and W. B. Davis. 1986. Protein permeability in the adult respiratory distress syndrome: loss of size selectivity of the alveolar epithelium. J. Clin. Invest. 78: 1513-1522.
34. Fowler, A. A., T. M. Hyers, B. J. Fisher, D. E. Bechard, R. M. Centor, and R. O. Webster. 1987. The adult respiratory distress syndrome: cell populations and soluble mediators in the air spaces of patients at high risk. Am. Rev. Respir. Dis. 136:1225-1231.
35. Arend, W. P., F. G. Joslin, R. C. Thompson, and C. H. Hannum. 1989. An IL-1 inhibitor from human monocytes: production and characterization of biologic properties. J. Immunol. 143:1851-1858.
36. Siler, T. M., J. E. Swierkosz, T. M. Hyers, A. A. Fowler, and R. O. Webster. 1989. Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp. Lung Res. 15:881-894.
37. Suter, P. M., S. Suter, E. Girardin, P. Roux-Lombard, G. E. Grau, and J. M. Dayer. 1992. High bronchoalveolar levels of tumor necrosis factor with its inhibitors, interleukin-1, interferon, and elastase, in patients with respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145:1016-1022.
38. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268-271.
39. Walz, A., R. Burgener, B. Car, M. Baggiolini, S. L. Kunkel, and R. M. Strieter. 1991. Structure and neutrophil activating properties of a novel inflammatory peptide (ENA-78) with homology to IL-8. J. Exp. Med. 174:1355-1362.
40. Leonard, E. J., T. Yoshiumura, A. Rot, K. Noer, A. Walz, M. Baggiolini, D. A. Walz, E. J. Goetzl, and C. W. Castor. 1991. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor. J. Leukocyte Biol. 49:258-265.
41. Anisowicz, A., L. Bardwell, and R. Sager. 1987. Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc. Natl. Acad. Sci. U.S.A. 84:7188-7192.
42. Tekamp-Olson, P., C. Galegos, D. Bauer, J. McClain, B. Sherry, M. Fabre, S. van Deventer, and A. Cerami. 1990. Cloning and characterization of cDNAs for murine macrophage inflammatory protein-2 and its human homologues. J. Exp. Med. 172:911-919.
43. Haskill, S., A. Peace, J. Morris, A. A. Sporn, A. Anisowicz, S. W. Lee, T. Smith, G. Martin, P. Ralph, and R. Sager. 1990. Identification of three related human GRO genes encoding cytokine functions. Proc. Natl. Acad. Sci. U.S.A. 87:7732-7736.
44. Proost, P., C. De Wolf-Peeters, R. Conings, G. Opdenakker, A. Billiau, and J. Van Damme. 1993. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells: in vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J. Immunol. 150:1000-1010.
45. Cohen, A. B., M. D. Stevens, E. J. Miller, M. A. Atkinson, G. Mullenbach, R. J. Maunder, T. R. Martin, J. P. Weiner-Kronish, and M. A. Matthay. 1993. Neutrophil-activating peptide-2 in patients with pulmonary edema from congestive heart failure of ARDS. Am. J. Physiol. 264:L490-495.
46. Bitterman, P. B., L. E. Saltzman, S. Adelberg, V. J. Ferrans, and R. G. Crystal. 1984. Alveolar macrophage replication: one mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J. Clin. Invest. 74:460-469.
47. Schall, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165-183.
48. Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. U.S.A. 84:5788-5792.
49. Wang, J. M., B. Sherry, M. J. Fivash, D. J. Kelvin, and J. J. Oppenheim. 1993. Human recombinant macrophage inflammatory protein α and β and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J. Immunol. 150: 3022-3029.
50. Alam, R., M. A. Lett-Brown, P. A. Forsythe, D. J. Anderson-Walters, C. Keanamore, C. Kormos, and J. A. Grant. 1992. Monocyte chemotactic and activating factor in a potent histamine-releasing factor for basophils. J. Clin. Invest. 89:723-728.
51. Kuna, P., S. R. Reddigari, D. Rucinski, J. J. Oppenheim, and A. P. Kaplan. 1992. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J. Exp. Med. 175:489-493.
52. Matsushima, K., C. G. Larsen, G. C. Dubois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1484-1490.
53. Standiford, T. J., M. W. Rolfe, S. L. Kunkel, J. P. Lunch, M. D. Burdick, A. R. Gilbert, M. B. Orringer, R. I. Whyte, and R. M. Strieter. 1993. Macrophage inflammatory protein-1: expression in interstitial lung disease. J. Immunol. 151:2852-2863.
54. Dinarello, C. A., and S. M. Wolff. 1993. The role of interleukin-1 in disease. N. Engl. J. Med. 328:106-113.
55. Moser, R., B. Schleiffenbaum, P. Groscurth, and J. Fehr. 1989. Interleukin-1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J. Clin. Invest. 83:444-455.
56. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1045-1049.
57. Standiford, T. J., S. L. Kunkel, S. H. Phan, B. J. Rollins, and R. M. Strieter. 1991. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-I expression from human type II like epithelial cells. J. Biol. Chem. 266:9912-9918.
58. Pugin, J., B. Ricou, K. P. Steinberg, P. M. Suter, and T. R. Martin. 1996. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1β. Am. J. Respir. Crit. Care Med. 153:1850-1856.
59. Symons, J. A., J. A. Eastgate, and G. W. Duff. 1991. Purification and characterization of a novel soluble receptor for interleukin-1. J. Exp. Med. 174:1251-1254.
60. Cerretti, D. P., C. J. Kozlosky, B. Mosley, N. Nelson, K. Van Ness, T. A. Greenstreet, C. J. March, S. R. Kronheim, T. Druck, L. A. Cannizzaro, K. Huebner, and R. A. Black. 1992. Molecular cloning of the imerleukin-1β converting enzyme. Science 1256:97-100.
61. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against executive tumor necrosis factor-α in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 4845-4849.
62. Sylvester, I., T. Yoshimura, M. Sticherling, J. M. Schroder, M. Ceska, P. Peichl, and E. J. Leonard. 1992. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J. Clin. Invest. 90:471-481.
63. Kurdowska, A., A. B. Cohen, and R. P. Baughman. 1994. Alpha-2-macroglobulin: IL-8 complexes and anti-IL-8 antibody: IL-8 complexes in the bronchoalveolar lavage fluids of patients with the adult respiratory distress syndrome (abstract). Am. Rev. Respir. Dis. 149: A358.
64. Darbonne, W. C., G. C. Rice, M. A. Mohler, T. Apple, C. A. Herbert, A. J. Valente, and J. B. Baker. 1991. Red blood cells area sink for interleukin-8, a leukocyte chemotaxin. J. Clin. Invest. 88:1362-1369.
65. Neote, K., J. Y. Mak, L. F. Kolakowski, Jr., and T. J. Schall. 1994. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 84:44-52.
66. Matthay, M. A., M. Sadick, M. Reichert, and W. C. Darbonne. 1995. Red blood cells function as a major clearance mechanism for chemokines (IL-8, MGSA, RANTES) in critically ill patients. Am. J. Respir. Crit. Care Med. 151:A318.
67. Wolpe, S. D., and A. Cerami. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 3:2565-2573.
68. Rot, A. 1992. Endothelial cell binding of NAP-1/IL-8: role of neutrophil emigration. Immunol. Today 13:291-294.
69. Rot, A. 1993. Neutrophil attractant/activation protein-I (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism. Eur. J. Immunol. 23:303-306.
70. Webb, L. M., M. U. Ehrengruber, I. Clark-Lewis, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin-8. Proc. Natl. Acad. Sci. U.S.A. 90: 7158-7162.